These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37954532)

  • 21. Eight-Year Trends in Direct-Acting Oral Anticoagulant Dosing, Based on Age and Kidney Function, in Patients With Atrial Fibrillation.
    Bezabhe WM; Bereznicki LR; Radford J; Wimmer BC; Salahudeen MS; Peterson GM
    J Patient Saf; 2022 Jun; 18(4):337-341. PubMed ID: 35617592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program.
    Perlman A; Horwitz E; Hirsh-Raccah B; Aldouby-Bier G; Fisher Negev T; Hochberg-Klein S; Kalish Y; Muszkat M
    Isr J Health Policy Res; 2019 Feb; 8(1):19. PubMed ID: 30709417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Direct Oral Anticoagulant Prescribing in Patients With Moderate to Severe Renal Impairment.
    Ting C; Rhoten M; Dempsey J; Nichols H; Fanikos J; Ruff CT
    Clin Appl Thromb Hemost; 2021; 27():1076029620987900. PubMed ID: 33517715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: A narrative review.
    van der Horst SFB; van Rein N; van Mens TE; Huisman MV; Klok FA
    Thromb Res; 2023 Nov; 231():135-140. PubMed ID: 37005194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burden of Inappropriate Prescription of Direct Oral Anticoagulants at Hospital Admission and Discharge in the Elderly: A Prospective Observational Multicenter Study.
    Bruneau A; Schwab C; Anfosso M; Fernandez C; Hindlet P
    Drugs Aging; 2019 Nov; 36(11):1047-1055. PubMed ID: 31486994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in anticoagulant prescribing: a review of local policies in English primary care.
    Ho KH; van Hove M; Leng G
    BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct Oral Anticoagulant (DOAC) Dosing in Patients with Non-valvular Atrial Fibrillation (NVAF) in the United Kingdom: A Retrospective Cohort Study Using CPRD Gold Database.
    Khachatryan A; Doobaree IU; Spentzouris G; Gusto G; Zawaneh Y; Mughal F; Anastassopoulou A; Manu M; Fay M
    Adv Ther; 2023 Feb; 40(2):504-520. PubMed ID: 36399317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and predictors of inappropriate dosing of direct oral anticoagulants.
    Ko HTK; Pham J; Anpalahan M
    Intern Med J; 2023 Oct; 53(10):1790-1795. PubMed ID: 36448650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis.
    Reyes JL; Herzog CA; Yan H; Roetker NS; Wetmore JB
    J Cardiovasc Pharmacol Ther; 2022; 27():10742484221142220. PubMed ID: 36472155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience.
    Elewa H; El-Makaty H; Ali Z
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):155-161. PubMed ID: 28978236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries.
    Wheelock KM; Ross JS; Murugiah K; Lin Z; Krumholz HM; Khera R
    JAMA Netw Open; 2021 Dec; 4(12):e2137288. PubMed ID: 34870678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
    Carnicelli AP; Hong H; Connolly SJ; Eikelboom J; Giugliano RP; Morrow DA; Patel MR; Wallentin L; Alexander JH; Cecilia Bahit M; Benz AP; Bohula EA; Chao TF; Dyal L; Ezekowitz M; A A Fox K; Gencer B; Halperin JL; Hijazi Z; Hohnloser SH; Hua K; Hylek E; Toda Kato E; Kuder J; Lopes RD; Mahaffey KW; Oldgren J; Piccini JP; Ruff CT; Steffel J; Wojdyla D; Granger CB;
    Circulation; 2022 Jan; 145(4):242-255. PubMed ID: 34985309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study.
    Lawal OD; Aronow HD; Shobayo F; Hume AL; Taveira TH; Matson KL; Zhang Y; Wen X
    Circulation; 2023 Mar; 147(10):782-794. PubMed ID: 36762560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis.
    Blomström Lundqvist C; Själander S; Garcia Rodriguez LA; Åkerborg Ö; Jin G; Caleyachetty A; Huelsebeck M; Bowrin K; Schaefer B; Mahdessian H; Hofmeister L; Levin LÅ
    J Med Econ; 2022; 25(1):1085-1091. PubMed ID: 35997241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescribers' views and experiences of using direct acting oral anticoagulants in the management of nonvalvular atrial fibrillation: A survey in remote and rural Scotland.
    Generalova D; Cunningham S; Leslie SJ; Rushworth G; McIver L; Stewart D
    Br J Clin Pharmacol; 2019 Oct; 85(10):2414-2422. PubMed ID: 31313317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation.
    Gustafson WL; Saunders J; Vazquez SR; Jones AE; Witt DM
    Pharm Pract (Granada); 2019; 17(4):1709. PubMed ID: 31897264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol.
    Bhat Y; Dixit A; Mistri A; Patel B; Quoraishi SH; Uprichard J
    BMC Neurol; 2019 Nov; 19(1):306. PubMed ID: 31783738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse outcomes associated with inappropriate direct oral anticoagulant starter pack prescription among patients with atrial fibrillation: a retrospective claims-based study.
    Feng Y; Pai CW; Seiler K; Barnes GD
    J Thromb Thrombolysis; 2021 May; 51(4):1144-1149. PubMed ID: 33389520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population.
    Gupta K; Trocio J; Keshishian A; Zhang Q; Dina O; Mardekian J; Nadkarni A; Shank TC
    BMC Cardiovasc Disord; 2019 Jun; 19(1):142. PubMed ID: 31195999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of risk factors for inappropriate and suboptimal initiation of direct oral anticoagulants.
    Howard M; Lipshutz A; Roess B; Hawes E; Deyo Z; Burkhart JI; Moll S; Shilliday BB
    J Thromb Thrombolysis; 2017 Feb; 43(2):149-156. PubMed ID: 27757787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.